Aclaris Therapeutics Inc
Research Aclaris Therapeutics Inc (ACRS) on Bullrun: market cap USD 913.75M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerACRS
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 913.75M
- Financial periodQ2 2026
- RevenueUSD 1.63M
- Net income-USD 21.51M
- Free cash flow-USD 19.91M
- Gross margin10.8%
Valuation Snapshot
latest market cap is USD 913.75M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 7.83M | -USD 64.92M | -USD 47.22M | 73.3% | -0.53 | USD 19.96M | n/a | USD 103.08M |
| FY2024 | USD 18.72M | -USD 132.07M | -USD 20.20M | 85.1% | -1.71 | USD 24.57M | n/a | USD 155.55M |
| FY2023 | USD 31.25M | -USD 88.48M | -USD 79.63M | 89.0% | -1.27 | USD 39.88M | USD 426.00K | USD 157.18M |
| FY2022 | USD 29.75M | -USD 86.91M | -USD 68.17M | 86.5% | -1.33 | USD 45.28M | USD 684.00K | USD 197.62M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 913.75M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 362.70M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 267.47M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 74.38M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 1.05B | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 890.26M | n/a | n/a | n/a |
About Aclaris Therapeutics Inc
Aclaris Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering and developing novel molecule product candidates for immuno-inflammatory diseases in the United States. The company product pipeline includes Bosakitug (ATI-045), an anti-thymic stromal lymphopoietin monoclonal antibody in Phase 2 trial to treat moderate to severe atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyps, and moderate to severe chronic obstructive pulmonary disease;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Aclaris Therapeutics Inc's market cap?
Aclaris Therapeutics Inc's market capitalization is USD 913.75M.
What does Aclaris Therapeutics Inc do?
Aclaris Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering and developing novel molecule product candidates for immuno-inflammatory diseases in the United States.